Mov Disord Vol 35, Suppl 1 Archives - Page 142 of 149 - MDS Abstracts

MDS Virtual Congress 2020
Epidemiology of Huntington’s Disease (HD) in the US Medicaid Population
A. Exuzides, S. Reddy, E. Chang, C. Paydar, G. Yohrling (South San Francisco, CA, USA)
Objective: To estimate the current prevalence of Huntington’s disease (HD) among Medicaid beneficiaries in the United States (US). Background: HD is a genetic, progressive, neurodegenerative…
MDS Virtual Congress 2020
Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials
S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)
Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
MDS Virtual Congress 2020
Development of Hypertrophic Olivary Degeneration Following Pontine Hemorrhage
K. Bird, M.H Saint-Hilaire, G. Curiale, S. O'Shea (Boston, MA, USA)
Objective: To increase awareness of the late post-stroke movement disorder associated with hypertrophic olivary degeneration. Background: A 65-year-old man with a past medical history significant…
MDS Virtual Congress 2020
Visual cortex involvement in the familial cortical myoclonic tremor with epilepsy type 1: a resting state-fMRI with regional homogeneity analysis
B. Wang, H.T Wang, Z.D Chen, W. Luo (Hangzhou, China)
Objective: The purpose of current study was to investigate regional synchronization of the whole brain in patients with familial cortical myoclonic tremor with epilepsy (FCMTE)…
MDS Virtual Congress 2020
Parkinson’s Disease and the Law: Motor and Non-Motor Determinants in Medical Courts Cases
P. Amami, D. Ziemele, A. Albanese (Rozzano, Italy)
Objective: We reviewed the legal issues involving PD patients in Italy and United Kingdom and correlated these findings with the clinical condition of the involved…
MDS Virtual Congress 2020
Patient survey on personal preferences and choices regarding Advance Care Planning(ACP) in Parkinson’s Disease(PD)
M. Khwaja, A. Chatterjee (Reading, United Kingdom)
Objective: Understanding patients' choices and preferences in the advanced stage Parkinson’s disease. Background: Surveys of patients' experiences are increasingly recognized as an essential part of…
MDS Virtual Congress 2020
Efficacy of unilateral thalamotomy by MRgFUS in essential tremor and Parkinson’s disease in a large cohort of patients
M.C Rodríguez Oroz, O. Parras, A. Gorospe, I. Aviles, P. Manrique, L. Gonzalez, J. Guridi (Navarre, Spain)
Objective: To evaluate the efficacy and adverse events of unilateral lesions of the ventral intermediate (VIM) nucleus of the thalamus (thalamotomy) by magnetic resonance guided…
MDS Virtual Congress 2020
Influencing factors when living with Parkinson’s disease: beyond the disease symptomatology
L. Ambrosio, P. Martinez-Martin, C. Rodriguez-Blazquez, M.C Portillo (Pamplona, Spain)
Objective: To identify which are the factors that influence in the process of living with Parkinson's disease (PD). Background: Living with PD is a complex,…
MDS Virtual Congress 2020
Unraveling the role of amylin oligomers in synucleinopathies
I. Martinez Valbuena, R. Valenti Azcarate, C. Caballero, I. Marcilla Garcia, I. Amat-Villegas, J. Sanchez, G. Marti-Andres, L. Armengou, M.R Luquin Piudo (Pamplona, Spain)
Objective: The aim of this work is to elucidate the role of amylin in both alpha-synuclein amyloid formation and Parkinson’s disease (PD) and dementia with…
MDS Virtual Congress 2020
Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms
C.Y Chua, M.E Koh, N.Y Chia, S.E Ng, S.E Saffari, M.C Wen, R.Y Chen, X. Choi, D.L Heng, S.X Neo, K.Y Tay, W.L Au, E.K Tan, L.S Tan, Z. Xu (Singapore, Singapore)
Objective: To determine the prevalence of Subjective Cognitive Complaints (SCC) in early Parkinson’s disease (PD) and examine the correlates between SCC in early PD and…